|
|
Application of transcervical resection of polyp combined with estrogen and progestin in patients with endometrial polyps |
JIANG Da-mei |
Department of Obstetrics and Gynecology,Ganzhou Municipal Hospital,Jiangxi Province,Ganzhou 341000,China |
|
|
Abstract Objective To investigate the application of trans-cervical resection of polyps (TCRP) regimen combined with estrogen and progestin in patients with endometrial polyps (EP) and evaluate its clinical effect.Methods A total of 106 patients with EP treated in our hospital from July 2016 to March 2018 were selected as the research subjects.They were divided into control group (n=53) and treatment group (n=53) according to the random number table method.TCRP method was used in the control group.In the treatment group,estrogen and progestin method was added on the basis of the control group.The endometrial thickness,menstrual blood loss,estrogen and progesterone,adverse reactions and recurrence were compared between the two groups.Results The thickness of endometrium at 12 months after surgery in the treatment group was thinner than that in the control group,the pictorial blood loss assessment chart(PBAC) score was lower than that in the control group,and the differences were statistically significant (P<0.05).The estrogen level was lower and the progesterone level in the treatment group was higher compared with those in the control group,the differences were statistically significant (P<0.05).There were no statistical differences in the endometrial thickness,PBAC score,estrogen and progesterone levels of the two groups (P>0.05).The incidence and recurrence rate of prolonged menstrual period,irregular vaginal bleeding,breast distending pain in the treatment group were lower than those in the control group,and the differences were statistically significant (P<0.05).Conclusion TCRP combined with estrogen and progestin is effective in treating patients with EP,and it is safe and reliable.It can effectively reduce the thickness of the endometrium,promote menstrual recovery,and reduces adverse reactions and disease recurrence,which is worthy of reference.
|
|
|
|
|
[1] |
姜伶俐,吴方跃.子宫内膜息肉的临床研究进展[J].中国当代医药,2018,25(28):29-31.
|
[2] |
马新想.宫腔镜下电切术治疗子宫内膜息肉不孕效果评价[J].实用中西医结合临床,2018,18(4):95-96.
|
[3] |
朱丽铭.TCRP 术后左炔诺孕酮宫内缓释系统对子宫内膜息肉合并贫血患者子宫内膜厚度和复发率的影响[J].中国民康医学,2018,30(21):53-54.
|
[4] |
周冠伦,张宁,李菲,等.子宫内膜息肉发病机制及临床诊疗策略的相关研究进展[J].中国内镜杂志,2017,23(8):77-80.
|
[5] |
朱求.阴道B超与宫腔镜对子宫内膜息肉的诊断价值对比研究[J].中国医疗器械信息,2018,24(24):151-152.
|
[6] |
刘瑾,陈远群,余志英,等.宫腔镜电切术联合去氧孕烯炔雌醇治疗子宫内膜息肉的临床分析[J].深圳中西医结合杂志,2015,25(5):9-11.
|
[7] |
罗琴,李力.宫腔镜电切术用于子宫内膜息肉致异常子宫出血患者的效果观察[J].临床医药文献电子杂志,2018,5(29):84.
|
[8] |
袁红,刘相蓉.炔诺酮联合TCRP 治疗子宫内膜息肉的临床效果及对患者月经改善情况的影响[J].临床医学研究与实践,2018,3(21):95-96.
|
[9] |
邓闹.宫腔镜下子宫内膜息肉切除术后不同处理对息肉复发的影响[J].现代诊断与治疗,2019,30(13):2221-2223.
|
[10] |
彭左艳,闫彩平,邓鹏飞,等.雌激素受体、孕激素受体及微血管密度在子宫内膜息肉不同部位和正常同期内膜上的表达研究[J].中国实用医药,2015,4(21):43-44.
|
[11] |
李红娟,王雅莉,刘楠,等.宫腔镜电切术联合妈富隆治疗子宫内膜息肉的临床疗效[J].中国实用医刊,2012,39(8):78-79.
|
[12] |
韩正枝.孕激素辅助宫腔镜子宫内膜息肉切除术治疗子宫内膜息肉的临床疗效及对子宫内膜血管内皮生长因子表达的影响[J].贵州医药,2017,41(3):294-296.
|
[13] |
彭雪冰.绝经期妇女子宫内膜息肉中雌激素受体,孕激素受体的表达特点及意义[J].医学信息(中旬刊),2011,24(8):3911-3912.
|
[14] |
覃晓,徐文生.TCRP 术后子宫内膜息肉复发相关因素研究[J].广西医科大学学报,2015,32(3):446-448.
|
[15] |
郑瑞芹,刘晓芹,张建英.子宫内膜息肉组织中雌、孕激素受体的表达[J].国际生殖健康(计划生育杂志),2010,29(4):263-264.
|
|
|
|